Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug applications (ANDAs).
administrator
Related Articles
Further Insights Into the Metabolism of LGD‐4033 in…
- December 10, 2025
Evaluation of an Innovative Portable Heroin Electrochemical Sensor…
- December 10, 2025